Antimicrobial Resistance Diagnostics Market Size, Share & Trends Report

Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microbiology Culture, Immunoassay, PCR, NGS), By Pathogen, By End User, By Region, And Segment Forecasts, 2022 - 2030

Report ID: GVR-4-68039-990-4
Number of Pages: 120
Format: Electronic (PDF)

Historical Range: 2018 - 2020
Industry: Healthcare

Market Segmentation

Antimicrobial Resistance Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Microbiology Culture
- Immunoassay
- PCR
- NGS
- Mass Spectrometry
- Rapid & Point of Care
- Others
Antimicrobial Resistance Diagnostics Pathogen Outlook (Revenue, USD Million, 2018 - 2030)
- Drug Resistant Streptococcus Pneumoniae (DRSP)
- Drug Resistant Campylobacter (DRC)
- Clostridium Difficile (CD)
- Methicillin Resistant Staphylococcus Aureus (MRSA)
- Drug Resistant Neisseria Gonorrhoeae (DRNG)
- Drug Resistant Salmonella (DRNTS)
- Others
Antimicrobial Resistance Diagnostics End-user Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
Antimicrobial Resistance Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Antimicrobial Resistance Diagnostics Market, By Technology
    - Microbiology Culture
    - Immunoassay
    - PCR
    - NGS
    - Mass Spectrometry
    - Rapid & Point of Care
    - Others
  - North America Antimicrobial Resistance Diagnostics Market, By Pathogen
    - Drug Resistant Streptococcus Pneumoniae (DRSP)
    - Drug Resistant Campylobacter (DRC)
    - Clostridium Difficile (CD)
    - Methicillin Resistant Staphylococcus Aureus (MRSA)
    - Drug Resistant Neisseria Gonorrhoeae (DRNG)
    - Drug Resistant Salmonella (DRNTS)
    - Others
  - North America Antimicrobial Resistance Diagnostics Market, By End-user
    - Hospitals
    - Diagnostic Laboratories
    - Pharmaceutical & Biotechnology Companies
    - Others
  - U.S.
    - U.S. Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - U.S. Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - U.S. Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Canada
    - Canada Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Canada Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Canada Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
- Europe
  - Europe Antimicrobial Resistance Diagnostics Market, By Technology
    - Microbiology Culture
    - Immunoassay
    - PCR
    - NGS
    - Mass Spectrometry
    - Rapid & Point of Care
    - Others
  - Europe Antimicrobial Resistance Diagnostics Market, By Pathogen
    - Drug Resistant Streptococcus Pneumoniae (DRSP)
    - Drug Resistant Campylobacter (DRC)
    - Clostridium Difficile (CD)
    - Methicillin Resistant Staphylococcus Aureus (MRSA)
    - Drug Resistant Neisseria Gonorrhoeae (DRNG)
    - Drug Resistant Salmonella (DRNTS)
    - Others
  - Europe Antimicrobial Resistance Diagnostics Market, By End-user
    - Hospitals
    - Diagnostic Laboratories
    - Pharmaceutical & Biotechnology Companies
    - Others
  - U.K.
    - U.K. Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - U.K. Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - U.K. Antimicrobial Resistance Diagnostics Market, By End user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Germany
    - Germany Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Germany Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Germany Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - France
    - France Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - France Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - France Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Italy
    - Italy Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Italy Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Italy Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Spain
    - Spain Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Spain Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Spain Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
- Asia Pacific
  - Asia Pacific Antimicrobial Resistance Diagnostics Market, By Technology
    - Microbiology Culture
    - Immunoassay
    - PCR
    - NGS
    - Mass Spectrometry
    - Rapid & Point of Care
    - Others
  - Asia Pacific Antimicrobial Resistance Diagnostics Market, By Pathogen
    - Drug Resistant Streptococcus Pneumoniae (DRSP)
    - Drug Resistant Campylobacter (DRC)
    - Clostridium Difficile (CD)
    - Methicillin Resistant Staphylococcus Aureus (MRSA)
    - Drug Resistant Neisseria Gonorrhoeae (DRNG)
    - Drug Resistant Salmonella (DRNTS)
    - Others
  - Asia Pacific Antimicrobial Resistance Diagnostics Market, By End-user
    - Hospitals
    - Diagnostic Laboratories
    - Pharmaceutical & Biotechnology Companies
    - Others
  - Japan
    - Japan Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Japan Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Japan Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - China
    - China Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - China Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - China Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - India
    - India Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - India Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - India Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - South Korea
    - South Korea Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - South Korea Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - South Korea Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Australia
    - Australia Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Australia Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Australia Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
- Latin America
  - Latin America Antimicrobial Resistance Diagnostics Market, By Technology
    - Microbiology Culture
    - Immunoassay
    - PCR
    - NGS
    - Mass Spectrometry
    - Rapid & Point of Care
    - Others
  - Latin America Antimicrobial Resistance Diagnostics Market, By Pathogen
    - Drug Resistant Streptococcus Pneumoniae (DRSP)
    - Drug Resistant Campylobacter (DRC)
    - Clostridium Difficile (CD)
    - Methicillin Resistant Staphylococcus Aureus (MRSA)
    - Drug Resistant Neisseria Gonorrhoeae (DRNG)
    - Drug Resistant Salmonella (DRNTS)
    - Others
  - Latin America Antimicrobial Resistance Diagnostics Market, By End-user
    - Hospitals
    - Diagnostic Laboratories
    - Pharmaceutical & Biotechnology Companies
    - Others
  - Brazil
    - Brazil Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Brazil Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Brazil Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Mexico
    - Mexico Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Mexico Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Mexico Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Argentina
    - Argentina Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Argentina Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Argentina Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
- Middle East & Africa
  - Middle East & Africa Antimicrobial Resistance Diagnostics Market, By Technology
    - Microbiology Culture
    - Immunoassay
    - PCR
    - NGS
    - Mass Spectrometry
    - Rapid & Point of Care
    - Others
  - Middle East & Africa Antimicrobial Resistance Diagnostics Market, By Pathogen
    - Drug Resistant Streptococcus Pneumoniae (DRSP)
    - Drug Resistant Campylobacter (DRC)
    - Clostridium Difficile (CD)
    - Methicillin Resistant Staphylococcus Aureus (MRSA)
    - Drug Resistant Neisseria Gonorrhoeae (DRNG)
    - Drug Resistant Salmonella (DRNTS)
    - Others
  - Middle East & Africa Antimicrobial Resistance Diagnostics Market, By End-user
    - Hospitals
    - Diagnostic Laboratories
    - Pharmaceutical & Biotechnology Companies
    - Others
  - South Africa
    - South Africa Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - South Africa Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - South Africa Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Saudi Arabia
    - Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - Saudi Arabia Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others
  - UAE
    - UAE Antimicrobial Resistance Diagnostics Market, By Technology
      - Microbiology Culture
      - Immunoassay
      - PCR
      - NGS
      - Mass Spectrometry
      - Rapid & Point of Care
      - Others
    - UAE Antimicrobial Resistance Diagnostics Market, By Pathogen
      - Drug Resistant Streptococcus Pneumoniae (DRSP)
      - Drug Resistant Campylobacter (DRC)
      - Clostridium Difficile (CD)
      - Methicillin Resistant Staphylococcus Aureus (MRSA)
      - Drug Resistant Neisseria Gonorrhoeae (DRNG)
      - Drug Resistant Salmonella (DRNTS)
      - Others
    - UAE Antimicrobial Resistance Diagnostics Market, By End-user
      - Hospitals
      - Diagnostic Laboratories
      - Pharmaceutical & Biotechnology Companies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.